Allergan (AGN) Wins FDA Panel Backing For Nocturia Treatment - Bloomberg

October 19, 2016 3:54 PM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Allergan (NYSE: AGN) Wins FDA Panel Backing For Nocturia Treatment - Bloomberg



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA, Hot FDA News

Add Your Comment